Critical Therapeutics, Mylan deal

CRTX received a $5 million milestone payment from MYL's Dey L.P. subsidiary under a 2007 deal to co-promote CRTX's Zyflo and Zyflo CR for asthma (see BioCentury, March 19). Zyflo is an immediate-rele...